IXICO plc (LON:IXI – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 11 ($0.14) and traded as high as GBX 12.50 ($0.15). IXICO shares last traded at GBX 12.50 ($0.15), with a volume of 510 shares traded.
IXICO Stock Performance
The stock has a 50 day moving average of GBX 11.12 and a two-hundred day moving average of GBX 9.34. The stock has a market capitalization of £5.99 million, a PE ratio of -309.50, a P/E/G ratio of -0.38 and a beta of 0.86. The company has a debt-to-equity ratio of 3.22, a current ratio of 3.64 and a quick ratio of 4.90.
Insiders Place Their Bets
In related news, insider Grant Nash bought 260,000 shares of IXICO stock in a transaction that occurred on Wednesday, December 4th. The shares were purchased at an average price of GBX 12 ($0.15) per share, with a total value of £31,200 ($38,390.55). 30.28% of the stock is owned by company insiders.
About IXICO
IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.
Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.
Further Reading
- Five stocks we like better than IXICO
- Investing In Preferred Stock vs. Common Stock
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Which Wall Street Analysts are the Most Accurate?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 3 Dividend Kings To Consider
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.